Sarcoma Research

At Fred Hutchinson Cancer Center, we’re studying how sarcomas develop, how they evade the body’s defenses and how to trigger the immune system to fight them.

 

Researchers and Patient Treatments

Dr. Warren Phipps

Our Sarcoma Researchers

Our interdisciplinary scientists and clinicians work together to prevent, diagnose and treat sarcoma as well as other cancers and diseases.

Meet Our Faculty
photo of sarcoma survivor with her family

Patient Treatment and Care

At Fred Hutch, our interdisciplinary teams work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our aim is to provide patients access to advanced treatment options while getting the best cancer care.

Request An Appointment

Selected Sarcoma Clinical Trials

Clinical research is an essential part of the scientific process that leads to new treatments and better care. Clinical trials can also be a way for patients to get early access to new cutting-edge new therapies. Our clinical research teams are running clinical studies on various kinds of sarcoma.

Immunotherapies

Targeted Drug Treatment

Immunotherapies

We’re world leaders in harnessing the immune system to attack cancer. A prime example is T-cell therapy, which deploys a specialized type of immune cell, the T cell. Hutch scientists are reprogramming patients’ own T cells to better recognize and target telltale markers on sarcomas. We run clinical trials that are combining radiation treatment with these T-cell therapies. And we test drugs called checkpoint inhibitors, which take the brakes off a patient’s immune system so it mounts a better response against sarcomas.

Sarcoma Research

Sarcoma research at Fred Hutch covers every aspect of the disease’s biology and treatment in children and adults. We study how sarcomas develop, how they respond to various therapies and how we can enhance the immune response against them.

Immunotherapies

We’re world leaders in harnessing the immune system to attack cancer. A prime example is T-cell therapy, which deploys a specialized type of immune cell, the T cell. Our scientists are reprogramming patients’ own T cells to better recognize and target telltale markers on sarcomas. We run clinical trials that are combining radiation treatment with these T-cell therapies. And we test drugs called checkpoint inhibitors, which take the brakes off a patient’s immune system so it mounts a better response against sarcomas.

Targeted Drug Therapies

We’re studying new drugs that target substances on or in sarcoma cells and disrupt their ability to grow and spread.

Latest Sarcoma News

SEE ALL SARCOMA NEWS
Laying the groundwork for a new cancer-preventive vaccine Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma November 18, 2024
Finding a calling in the midst of chemo Fred Hutch mammographer discovers new career path during own cancer treatment November 8, 2024
Outstanding people are the Heart of the Hutch Fred Hutch clinical and admin teams share their passion for helping patients, faculty July 16, 2024
Dr. Elizabeth Loggers recognized as national palliative care leader Expertise helps her better support and care for patients with sarcoma May 15, 2024